OnCall+ Eye Health Contributor
Jay Pepose, M.D.
Aug. 27, 2009 -- Dr. Jay Pepose is a board certified cornea and vision correction surgery subspecialist. He specializes in laser vision correction, cataract and cornea surgery. A pioneer in laser eye surgery to correct nearsightedness, farsightedness and astigmatism, Dr. Jay Pepose was the first to introduce LASIK vision correction to the St. Louis region. As one of the original 10 eye surgeons nationwide to participate in clinical trials of the excimer laser to correct mild to severe degrees of myopia and astigmatism, Dr. Pepose is regarded as a leading authority on laser vision correction diagnostics and outcomes. He was one of an elite group of eye surgeons that conducted a nationwide clinical trial that made LASIK available for the correction of farsightedness and astigmatism. Dr. Pepose is involved in many clinical trials related to the newest generation of multifocal lens implants for cataract patients, as well as clinical studies of more precise measurement devices for glaucoma and new treatments for presbyopia (age-related weakening of near vision).
Dr. Pepose serves as ophthalmic consultant for ABC TV's 20/20 program and web site. His work in laser vision correction has been featured at the Frontiers of Medicine pavilion at Epcot Center in Orlando, Florida. As an invited speaker, he has lectured extensively throughout the world, including Korea, Japan, England, Israel and Australia.
Prior to founding the Pepose Vision Institute, Dr. Pepose held the Bernard Becker Professorship in Ophthalmology and Visual Sciences, Washington University School of Medicine. Dr. Pepose is the recipient of numerous honors and awards, including the prestigious Cogan award from the Association for Research in Vision and Ophthalmology. He is recognized in "Best Doctors in America" and "America's Top Docs" as a noted subspecialist in cataract, corneal and vision correction surgery, the only such specialist in the St. Louis region to be so honored. Dr. Pepose has contributed extensively to the scientific literature, holds two patents, and has been the recipient of competitive National Eye Institute research support. He serves on the editorial board of several prestigious ophthalmology journals and is associate editor of The American Journal of Ophthalmology. Most recently, he has been appointed to the Board of Calhoun Vision, a California based innovator in emerging vision technologies.